COT.V
Critical Outcome Technologies Inc.
TSXV
People also watch:IMM.VMBI.VCZO.VCOV.VSVA.V
0.67-0.01 (-1.47%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close0.68
Open0.69
Bid0.66 x
Ask0.67 x
52wk Range0.20 - 0.90
Day's Range0.66 - 0.69
Volume164,893
Avg Vol (3m)162,657
As of 3:45 PM EDT. Market closed.
  • Zacks Small Cap Research2 months ago

    COTI: Balance Sheet Boosted by New Financings

    By Grant Zeng, CFA TSX:COT.V On March 17 , 2016, COTI (TSX:COT.V) announced that it realized gross proceeds of $1,447,125 upon the exercise of 4,823,750 common share purchase warrants that would otherwise ...

  • Zacks Small Cap Research4 months ago

    COT.V: ROSALIND Technology Targets the Huge Gene Profiling Market

    Critical Outcome Technologies Inc. (COT.V) is a clinical stage biopharmaceutical Company which is focused on the discovery and development of cancer treatments through targeted therapeutics. In addition to CHEMSAS®, COTI has also developed ROSALIND. ROSALIND is a computer platform for realizing the promise of personalized medicine for cancer patients.